Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease

Summary

Tongxinluo is a kind of Chinese patent drug,which could promote blood circulation.Recent reports suggested that tongxinluo's effectiveness in reducing the thrombin activity.In this prospective randomized study,all patients in control group will receive blank placebo ,all patients in test group will receive tongxinluo.All patients will be followed up for one year.

Timeline

Start

2012-11

Primary completion

2013-05

Completion

2014-06

Drugs

Indications